The drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin) has received FDA approval and can be used effectively for the treatment of acute myeloid leukemia. The drug is used in the complex targeted therapy of the disease. The medicine is manufactured by the renowned pharmaceutical company Pfizer. Description An effective antitumor drug is a conjugate of moloclonal antibodies to CD33 and an antibacterial substance calicheamicin. Available as a solution for intravenous injection. Means Milotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin) to buy a can of a below-market price.
Side effects In some cases, the medicine causes: • headaches; • stool disorders; • nausea, vomiting; • insomnia; • depression; • neurological disorders; • dizziness; • jumps in blood pressure. A pronounced manifestation of adverse reactions requires consultation with your doctor. In some situations, fever and hypoxemia may develop. The drug is stored in a refrigerator at t 2-8 degrees. Do not freeze the vial with the medicinal composition. For the drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin), the cost does not have extra markups.
©2020 CopyRight Onco24.com. All rights reserved.